-
GPR30 in Spinal CCK+ Neurons and Neuropathic Pain
2026-08-14
Chen and colleagues identify GPR30-expressing spinal CCK+ neurons as a cell population that links nerve injury, AMPA-mediated synaptic enhancement, and neuropathic pain behavior. Their combination of cell-type-specific inhibition, synaptic analysis, and S1-to-spinal-cord circuit manipulation provides a framework for studying estrogen-sensitive pain pathways while also clarifying the limits of current circuit evidence.
-
CGRP/SP–Piezo2 Axis in Trigeminal Allodynia
2026-08-14
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cell-based experiments connect ATP, PKC, ERK1/2, p38 MAPK, and Merkel-cell mechanotransduction, providing a mechanistic framework for peripheral sensitization in trigeminal neuralgia.
-
Perospirone: Receptor and Kv1.5 Research Guide
2026-08-13
Perospirone, also known as SM-9018 free base, combines high-affinity 5-HT2A and dopamine D2 receptor antagonism with 5-HT1A partial agonism. Recent cellular evidence identifies concentration-dependent inhibition of vascular Kv1.5 currents, extending its research relevance from schizophrenia models to cardiovascular electrophysiology.
-
Naloxone Hydrochloride: Research Mechanisms
2026-08-13
Naloxone hydrochloride is a competitive opioid receptor antagonist for mechanistic studies of opioid receptor signaling, overdose reversal, addiction biology, and neural stem cell proliferation modulation. The B8208 product combines a defined hydrochloride salt with water and DMSO solubility information, while experimental evidence supports receptor-dependent and receptor-independent research applications.
-
AMPK–SQSTM1 Feedback in Metabolic Stress
2026-08-12
This 2024 Autophagy study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that simultaneously activates AMPK and NFE2L2/NRF2 during metabolic stress. Its mechanistic model links lysosomal deacidification, TFEB/TFE3 regulation, TAK1-dependent p62 phosphorylation, KEAP1 degradation, and AXIN–STK11–AMPK assembly, clarifying how tumor cells coordinate energy and antioxidant defenses.
-
Amyloid Beta-peptide (25-35): Applied Workflows
2026-08-12
Build a reproducible Aβ25-35 neurotoxicity workflow for neuronal injury, oxidative stress, amyloid aggregation studies, and microglial signaling. This guide connects practical peptide handling with the FLOT1-FOSL2-EphA2 findings to improve mechanism-focused assay design.
-
Human Intestinal Organoids with Tunable Cell Fate
2026-08-11
This reference study establishes a human small intestinal organoid system that maintains high proliferation while expanding epithelial cell diversity under a single culture condition. Its central innovation is the use of small-molecule modulation to strengthen stemness and then tune differentiation toward secretory, enterocyte, or other intestinal lineages without recreating artificial spatial signaling gradients.
-
HRP Rabbit Anti-Goat IgG (H+L) Antibody
2026-08-11
This scenario-driven guide explains how HRP Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1224, can strengthen orthogonal protein-validation workflows alongside cell viability, proliferation, and cytotoxicity assays. It covers species compatibility, application-specific dilutions, storage, controls, interpretation, and practical vendor-selection criteria.
-
AM 281 for CB1 Signaling in TBI Research
2026-08-10
AM 281 is a high-affinity CB1 cannabinoid receptor antagonist for separating CB1-driven signaling from glutamate transport and neuronal injury outcomes. This workflow translates recent CB1–CREB–GLT-1 findings into practical time-course, formulation, behavioral, and troubleshooting decisions for neuropharmacology research.
-
Staurosporine Workflows for Kinase and Apoptosis Studies
2026-08-09
Build more informative cell-based assays with Staurosporine, combining broad kinase perturbation with time-resolved microscopy of fractional killing. The workflow also supports carefully bounded studies of receptor signaling and tumor angiogenesis without confusing cytotoxicity with pathway-specific proof.
-
Bone Transport and TGF-β1 in Diabetic Foot Ulcers
2026-08-08
This rat study identifies TGF-β1/TGFBR1 signaling as a mechanistic link between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. Its multimodal design suggests that bone transport promotes healing through coordinated osteo-immune and vascular responses, while pathway inhibition weakens these benefits.
-
CCK-8, Endogenous Opioids, and Morphine Withdrawal Anxiety
2026-08-07
This study shows that centrally administered cholecystokinin octapeptide (CCK-8) reduces anxiety-like behavior during morphine withdrawal in rats through CCK1 receptor involvement and endogenous opioid signaling. Its pharmacological design identifies a mechanistic link between a brain–gut peptide and the negative affective component of opioid dependence, while also highlighting important limits for translation to clinical opioid addiction and withdrawal studies.
-
Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis
2026-08-07
This study introduces a four-gene ferroptosis-related prognostic model for hepatocellular carcinoma (HCC), and experimentally identifies atorvastatin as a promising agent that induces ferroptosis in HCC cells. The research bridges bioinformatics and experimental oncology, offering new routes for biomarker-driven prognosis and targeted therapy in liver cancer.
-
GET3-Dependent Tail-Anchoring of MCL1 Regulates Apoptosis
2026-08-06
This study uncovers the essential role of GET3 in anchoring MCL1 to cellular membranes, directly regulating apoptosis during mitotic arrest. The findings highlight a mechanistic link between the GET pathway and mitochondrial apoptotic signaling, with implications for targeting MCL1 in cancer research.
-
Decoding DNA Damage: Advanced γH2AX Kit Applications in Prec
2026-08-06
Explore how the γH2AX DNA Damage Detection Kit enables next-generation DNA damage and repair studies. Learn why γ-H2AX is a gold-standard biomarker and how state-of-the-art immunofluorescence unlocks breakthrough insights in cancer and genotoxicity research.